|
|
|
|
|
|
|
|
|
|
Previous: EBT INTERNATIONAL INC, 10-Q, 2000-12-15 |
Next: GUILFORD PHARMACEUTICALS INC, 8-K, 2000-12-15 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND THE CONSOLIDATED STATEMENTS OF OPERATIONS FILED
AS PART OF THE QUARTERLY REPORT ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> JAN-31-2001
<PERIOD-START> FEB-01-2000
<PERIOD-END> OCT-31-2000
<CASH> 71,461
<SECURITIES> 0
<RECEIVABLES> 3,404
<ALLOWANCES> 1,083
<INVENTORY> 0
<CURRENT-ASSETS> 81,987
<PP&E> 2,597
<DEPRECIATION> 0
<TOTAL-ASSETS> 87,250
<CURRENT-LIABILITIES> 13,025
<BONDS> 0
0
0
<COMMON> 169
<OTHER-SE> 72,963
<TOTAL-LIABILITY-AND-EQUITY> 73,132
<SALES> 11,896
<TOTAL-REVENUES> 18,477
<CGS> 2,766
<TOTAL-COSTS> 7,641
<OTHER-EXPENSES> 31,025
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 18,599
<INCOME-TAX> 300
<INCOME-CONTINUING> 18,299
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 18,299
<EPS-BASIC> $1.10
<EPS-DILUTED> $1.07
</TABLE>
|
|